These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11071372)

  • 1. Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.
    Shields DC; Avgeropoulos NG; Banik NL; Tyor WR
    Neurochem Res; 2000 Nov; 25(11):1517-20. PubMed ID: 11071372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.
    Kalincik T; Horakova D; Dolezal O; Krasensky J; Vaneckova M; Seidl Z; Havrdova E
    Clin Neurol Neurosurg; 2012 Sep; 114(7):940-6. PubMed ID: 22402204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis.
    Totaro R; Passacantando A; Russo T; Parzanese I; Rascente M; Marini C; Tonietti G; Carolei A
    Int J Immunopathol Pharmacol; 2005; 18(2):377-83. PubMed ID: 15888259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-β or azathioprine as add-on therapies in patients with active multiple sclerosis.
    Ticha V; Kalincik T; Havrdova E
    Neurol Res; 2012 Dec; 34(10):923-30. PubMed ID: 22910063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E; Zivadinov R; Krasensky J; Dwyer MG; Novakova I; Dolezal O; Ticha V; Dusek L; Houzvickova E; Cox JL; Bergsland N; Hussein S; Svobodnik A; Seidl Z; Vaneckova M; Horakova D
    Mult Scler; 2009 Aug; 15(8):965-76. PubMed ID: 19465443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis therapy. A practical guide.
    van Oosten BW; Truyen L; Barkhof F; Polman CH
    Drugs; 1995 Feb; 49(2):200-12. PubMed ID: 7729328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect meta-analytical comparison of azathioprine and of beta interferon effectiveness in all forms of multiple sclerosis pooled together.
    Messori A; Fadda V; Maratea D; Trippoli S
    J Neurol Sci; 2014 Dec; 347(1-2):408-10. PubMed ID: 25455308
    [No Abstract]   [Full Text] [Related]  

  • 9. Wegener's granulomatosis. Combined therapy with low-dosage systemic corticosteroids, azathioprine and cyclophosphamide in three patients.
    Keczkes K
    Br J Dermatol; 1976 Apr; 94(4):391-9. PubMed ID: 1268053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroids in combination therapy for multiple sclerosis.
    Cohen JA
    Lancet Neurol; 2009 Jun; 8(6):502-3. PubMed ID: 19409855
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple sclerosis.
    Ford H; Nicholas R
    Clin Evid; 2005 Dec; (14):1637-51. PubMed ID: 16620466
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimization of the safety and efficacy of interferon beta 1b and azathioprine combination therapy in multiple sclerosis.
    Pulicken M; Bash CN; Costello K; Said A; Cuffari C; Wilterdink JL; Rogg JM; Mills P; Calabresi PA
    Mult Scler; 2005 Apr; 11(2):169-74. PubMed ID: 15794390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.
    Patti F; Amato MP; Filippi M; Gallo P; Trojano M; Comi GC
    J Neurol Sci; 2004 Aug; 223(1):69-71. PubMed ID: 15261564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Devic disease].
    Papeix C
    Presse Med; 2006 Nov; 35(11 Pt 2):1703-1706. PubMed ID: 17086129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive treatment of multiple sclerosis.
    Carter JL; Rodriguez M
    Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy in multiple sclerosis.
    Conway D; Cohen JA
    Lancet Neurol; 2010 Mar; 9(3):299-308. PubMed ID: 20170843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Wegener's granulomatosis.
    Briedigkeit L; Ulmer M; Göbel U; Natusch R; Reinhold-Keller E; Gross WL
    Adv Exp Med Biol; 1993; 336():491-5. PubMed ID: 8296663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive treatment in multiple sclerosis].
    Vermeulen M; Zegerius L; van Crevel H
    Ned Tijdschr Geneeskd; 1987 Jan; 131(3):93-6. PubMed ID: 3821989
    [No Abstract]   [Full Text] [Related]  

  • 19. Recovery from severe dysphagia in systemic sclerosis - myositis overlap: a case report.
    Chinniah KJ; Mody GM
    Afr Health Sci; 2017 Jun; 17(2):593-596. PubMed ID: 29062359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
    Patti F; Reggio E; Palermo F; Fiorilla T; Politi G; Nicoletti A; Reggio A
    J Neurol; 2004 Dec; 251(12):1502-6. PubMed ID: 15645351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.